European Healthtech startup funding raised during March 2021.
In March 2021, 35 European Healthtech companies raised a combined €494M across 35 funding rounds, up 72.0% versus March 2020. Germany led by capital raised, and Mercia Fund Managers was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Atai Life Sciences | Series D+ | Mar 2021 | €131M |
| Monte Rosa | Series C | Mar 2021 | €80M |
| MedAlliance | Other | Mar 2021 | €42M |
| Leyden Labs | Series A |
| Mar 2021 |
| €57M |
| Mar 2021 |
| €40M |
| PlusDental | Other | Mar 2021 | €35M |
| Ibex Medical Analytics | Series B | Mar 2021 | €32M |
| Augmedics | Other | Mar 2021 | €31M |
| Manual | Series A | Mar 2021 | €25M |
| Oxehealth | Other | Mar 2021 | €12M |
| ForSight Robotics | Seed | Mar 2021 | €8.4M |
| Clinomic | Other | Mar 2021 | €7.0M |
| Barkibu | Other | Mar 2021 | €4.7M |
| Apaleo | Other | Mar 2021 | €4.5M |
| Inotec Amd | Series C | Mar 2021 | €4.3M |
| Cytoseek | Seed | Mar 2021 | €4.1M |
